Ligand validation:6GE6

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 6GE6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GE6_MYR_A_501	4%	67%	0.24	0.618	0.34	0.93	-	-	2	0	100%	1
8A8R_MYR_A_501	29%	58%	0.188	0.848	0.41	1.19	-	1	1	0	100%	1
8C17_MYR_A_503	25%	68%	0.222	0.856	0.74	0.52	-	-	4	0	100%	1
6Q36_MYR_B_501	20%	67%	0.24	0.844	0.34	0.92	-	-	0	0	100%	1
6GEI_MYR_A_501	20%	68%	0.178	0.778	0.33	0.88	-	-	1	0	100%	1
6GE3_MYR_A_501	17%	37%	0.241	0.823	1.26	1.23	2	1	2	0	100%	1
9LVX_MYR_B_104	100%	70%	0.032	0.99	0.36	0.79	-	-	3	0	100%	1
3A73_MYR_A_1005	99%	46%	0.049	0.98	0.51	1.55	-	2	6	0	100%	1
8Q3D_MYR_C_101	99%	69%	0.046	0.974	0.53	0.66	-	-	0	0	100%	1
1AYM_MYR_4_4000	97%	73%	0.075	0.988	0.45	0.59	-	-	0	0	100%	1
8Q2Z_MYR_C_201	93%	68%	0.081	0.975	0.46	0.77	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.